We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

293 hedge funds and large institutions have $6.06B invested in PRA Health Sciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 100 increasing their positions, 124 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

234% more call options, than puts

Call options by funds: $8.86M | Put options by funds: $2.65M

16% more capital invested

Capital invested by funds: $5.24B → $6.06B (+$821M)

3% less funds holding

Funds holding: 301293 (-8)

16% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 45

19% less repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 124

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
293
Holders Change
-8
Holders Change %
-2.66%
% of All Funds
6.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
38
Increased
100
Reduced
124
Closed
45
Calls
$8.86M
Puts
$2.65M
Net Calls
+$6.21M
Net Calls Change
+$1.74M
Name Holding Trade Value Shares
Change
Change in
Stake
SBH
176
Segall Bryant & Hamill
Illinois
$911K +$199K +2,140 +30%
Public Employees Retirement Association of Colorado
177
Public Employees Retirement Association of Colorado
Colorado
$897K
BNP Paribas Financial Markets
178
BNP Paribas Financial Markets
France
$885K +$542K +5,822 +178%
KCM
179
Kendall Capital Management
Maryland
$875K -$95.4K -1,025 -10%
VRS
180
Virginia Retirement Systems
Virginia
$856K -$1.35M -14,500 -62%
CIC
181
Cornercap Investment Counsel
Georgia
$853K -$100K -1,079 -11%
SAMH
182
Shanda Asset Management Holdings
British Virgin Islands
$851K
TI
183
Trexquant Investment
Connecticut
$794K -$263K -2,830 -26%
RJA
184
Raymond James & Associates
Florida
$788K -$391K -4,201 -34%
ACM
185
Advisors Capital Management
New Jersey
$781K +$43.9K +472 +6%
SG Americas Securities
186
SG Americas Securities
New York
$780K +$359K +3,862 +93%
CGH
187
Crossmark Global Holdings
Texas
$768K +$52.9K +568 +8%
Los Angeles Capital Management
188
Los Angeles Capital Management
California
$754K +$85K +913 +13%
US Bancorp
189
US Bancorp
Minnesota
$753K +$136K +1,460 +23%
RG
190
Renaissance Group
Kentucky
$738K -$6.05K -65 -0.9%
RIM
191
Redwood Investment Management
Arizona
$729K -$14.4K -155 -2%
Zurich Cantonal Bank
192
Zurich Cantonal Bank
Switzerland
$711K +$211K +2,271 +45%
CF
193
CNA Financial
Illinois
$702K +$105K +1,132 +19%
MC
194
Maverick Capital
Texas
$682K +$652K +7,010 New
AI
195
Axiom Investors
Connecticut
$681K -$720K -7,732 -52%
AAMU
196
Amundi Asset Management US
Massachusetts
$660K
GH
197
GAM Holding
Switzerland
$658K -$63.6K -683 -9%
CSS
198
Cubist Systematic Strategies
Connecticut
$657K +$6.61K +71 +1%
SAM
199
Securian Asset Management
Minnesota
$624K -$9.31K -100 -2%
TC
200
TwinBeech Capital
New York
$624K +$597K +6,410 New

PRAH Hedge Fund Activity: Q2 2020 in Review

293 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2020, worth a combined $6.06B — up 16% from $5.24B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of PRAH and 38 opened new positions — a net loss of 7 holders — while 124 trimmed existing stakes and 100 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $174M. The largest seller was Eagle Asset Management, cutting an estimated $51.5M.

  • 293 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2020, down from 301 in Q1 2020.
  • Funds reported $6.06B of PRA Health Sciences, Inc. stock for Q2 2020, up 16% quarter-over-quarter.
  • 38 funds opened new PRA Health Sciences, Inc. positions in Q2 2020 and 45 closed out, a net change of -7 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q2 2020 was Massachusetts Financial Services, an estimated $174M added.
  • The largest PRA Health Sciences, Inc. seller in Q2 2020 was Eagle Asset Management, an estimated $51.5M sold.

Based on aggregated 13F filings for Q2 2020.